Download presentation
Presentation is loading. Please wait.
Published byKaare Nygård Modified over 5 years ago
1
A Double-Blind Placebo-Controlled Study of Intravenous Clodronate for Prevention of Steroid-Induced Bone Loss in Inflammatory Bowel Disease Vered Abitbol, Karine Briot, Christian Roux, Carine Roy, Philippe Seksik, Antoine Charachon, Yoram Bouhnik, Benoit Coffin, Matthieu Allez, Dominique Lamarque, Stanislas Chaussade Clinical Gastroenterology and Hepatology Volume 5, Issue 10, Pages (October 2007) DOI: /j.cgh Copyright © 2007 AGA Institute Terms and Conditions
2
Figure 1 Trial profile. Clinical Gastroenterology and Hepatology 2007 5, DOI: ( /j.cgh ) Copyright © 2007 AGA Institute Terms and Conditions
3
Figure 2 BMD changes during 1 year in placebo and clodronate groups.
Clinical Gastroenterology and Hepatology 2007 5, DOI: ( /j.cgh ) Copyright © 2007 AGA Institute Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.